Retail sale of pharmaceutical products
SVEGAARDEN PHARMAINVEST AS
Revenue 2024
NOK 7.0m
Operating profit
NOK 22,000
Equity
NOK −82,000
Incorporated
2024
Employees
6
Share capital
NOK 30,000
Key figures · 2024
Current ratio
1.33
Equity ratio
-2.1%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 0.3% | |
| Net margin (%%) | -1.5% | |
| Return on assets (%%) | 0.6% | |
| Likviditet | ||
| Current ratio | 1.33 | |
| Working capital | 632k | |
| Soliditet | ||
| Equity ratio (%%) | -2.1% | |
| Debt-to-equity ratio | -48.53 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.